Table 3.
Summary of meta-analysis results and grade evaluation.
| Index | Number of included studies | SMD/MD/RR (95% CI) | P value | I 2 value (%) | GRADE |
|---|---|---|---|---|---|
| Total effective rate | 20 | 1.10 (1.04, 1.17) | <0.05 | 32 | ⊕⊕○○Low |
| E 2 | 19 | 0.70 (0.14, 1.26) | <0.05 | 95 | ⊕⊕○○Low |
| FSH | 19 | −0.50 (−0.81, −0.18) | <0.05 | 87 | ⊕⊕○○Low |
| LH | 17 | −0.29 (−0.64, 0,09) | 0.12 | 89 | ⊕⊕○○Low |
| Ovarian volume | 3 | 0.07 (−0.17, 0.31) | 0.56 | 0 | ⊕⊕⊕○Moderate |
| Kupperman score | 7 | −0.78 (−1.24, -0.31) | <0.05 | 81 | ⊕⊕○○Moderate |
| PSV of ovarian stromal blood | 2 | 0.45 (0.16, 0.74) | <0.05 | 0 | ⊕⊕⊕○Moderate |
| Nausea | 3 | 0.02 (0.00, 0.11) | <0.05 | 0 | ⊕⊕⊕○Moderate |
| Vomiting | 3 | 0.03 (0.01, 0.16) | <0.05 | 0 | ⊕⊕⊕○Moderate |
| Ventosity | 5 | 1.28 (0.42, 3.87) | 0.67 | 0 | ⊕⊕⊕○Moderate |
| Headache | 5 | 0.25 (0.09, 0.65) | <0.05 | 0 | ⊕⊕⊕○Moderate |
| Breast pain | 8 | 0.12 (0.06, 0.24) | <0.05 | 0 | ⊕⊕⊕○Moderate |
| Edema | 3 | 0.15 (0.03, 0.80) | <0.05 | 0 | ⊕⊕⊕○Moderate |
| Vaginal bleeding | 4 | 0.17 (0.09, 0.36) | <0.05 | 0 | ⊕⊕⊕○Moderate |